038530 Stock Chart & Stats
₩804.00
₩24.00(3.08%)
―
--
Day’s Range― - ―
52-Week Range₩735.00 - ₩2,750.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)129.62K
Market Cap
₩17.88B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.34
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding23,142,870
10 Day Avg. Volume108,809
30 Day Avg. Volume129,617
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
038530 FAQ
What was KBIO LABS Inc.’s price range in the past 12 months?
KBIO LABS Inc. lowest stock price was ₩735.00 and its highest was ₩2750.00 in the past 12 months.
What is KBIO LABS Inc.’s market cap?
KBIO LABS Inc.’s market cap is ₩17.88B.
When is KBIO LABS Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were KBIO LABS Inc.’s earnings last quarter?
KBIO LABS Inc. released its earnings results on May 15, 2026. The company reported ₩27.307 earnings per share for the quarter, beating the consensus estimate of N/A by ₩27.307.
Is KBIO LABS Inc. overvalued?
According to Wall Street analysts KBIO LABS Inc.’s price is currently Undervalued.
Does KBIO LABS Inc. pay dividends?
KBIO LABS Inc. does not currently pay dividends.
What is KBIO LABS Inc.’s EPS estimate?
KBIO LABS Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does KBIO LABS Inc. have?
KBIO LABS Inc. has 23,142,870 shares outstanding.
What happened to KBIO LABS Inc.’s price movement after its last earnings report?
KBIO LABS Inc. reported an EPS of ₩27.307 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -9.084%.
Which hedge fund is a major shareholder of KBIO LABS Inc.?
Currently, no hedge funds are holding shares in KR:038530
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Abpro Bio Co., Ltd.
―
HUMASIS Co., Ltd.
―
SD Biotechnologies Co., Ltd.
―
From Bio Co., Ltd.
―
Plasmapp Co. Ltd.
―